Publications by authors named "Giulia Calabrese"

A nanocomposite sensor has been developed by integrating halloysite nanotubes (HNTs), kojic acid (K), and Cu ions (HNTK-Cu), marking a significant advancement in the field of dopamine detection. This cutting-edge sensor leverages the synergistic properties of its components to deliver exceptional analytical performance with promising implications for biomedical diagnostics and food safety monitoring. This innovative sensor exploits the unique properties of halloysite nanotubes and kojic acid to achieve a superior performance.

View Article and Find Full Text PDF

The ability to amplify motor neuron (MN) output is essential for generating high-intensity motor actions. This is critical for breathing that must be rapidly adjusted to accommodate changing metabolic demands. While brainstem circuits generate the breathing rhythm, the pathways that directly augment respiratory MN output are not well understood.

View Article and Find Full Text PDF

The ability to amplify motor neuron (MN) output is essential for generating high intensity motor actions. This is critical for breathing that must be rapidly adjusted to accommodate changing metabolic demands. While brainstem circuits generate the breathing rhythm, the pathways that directly augment respiratory MN output are not well understood.

View Article and Find Full Text PDF
Article Synopsis
  • - This study focused on assessing the long-term effects of neridronate treatment on patients with Complex Regional Pain Syndrome type 1 (CRPS-1), a condition that causes severe pain and disability, particularly in the upper limbs.
  • - A retrospective analysis included 49 patients who received neridronate infusions, revealing that 93.9% of them experienced a complete resolution of symptoms after an average follow-up of about 4 years, with 77.6% showing no functional limitations.
  • - Key factors influencing residual disability post-treatment were found to be younger age and the delay between the onset of the disease and the start of treatment, suggesting that earlier intervention may lead to better recovery outcomes.
View Article and Find Full Text PDF

Guselkumab is the first approved human IgG1λ monoclonal antibody selectively targeting the p19 subunit of IL23. Its effectiveness and safety were widely reported by clinical trials. However, these results must be confirmed in real life since its safety deals with more complicated subjects with respect to trials.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effects of dupilumab exposure during pregnancy in women with atopic dermatitis, focusing on safety and outcomes for both mothers and infants.
  • Researchers analyzed data from 19 hospitals in Italy, identifying 29 pregnant patients who used dupilumab, with the majority reporting unplanned pregnancies and stopping the medication when they learned of their pregnancy.
  • The findings indicated no significant risks associated with dupilumab for adverse pregnancy or neonatal outcomes, suggesting safety for its use in early pregnancy, but further monitoring is recommended for continued use throughout pregnancy.
View Article and Find Full Text PDF

Introduction: Patients undergoing a total thyroidectomy for multinodular goiter typically have a long clinical history of the disease. They often come to surgery for compression symptoms, with no suspicion of neoplastic disease. For these patients, the incidence of microcarcinomas is high, even though we know that this does not affect subsequent therapies and long-term survival.

View Article and Find Full Text PDF
Article Synopsis
  • Down syndrome (DS) is the most prevalent chromosomal disorder, with patients often experiencing skin issues like psoriasis and atopic dermatitis, which can be treated with biological drugs.
  • A study examined the effectiveness of these drugs in 7 patients (4 adults and 3 minors), revealing significant improvement in psoriasis symptoms over 24 weeks, with reductions in severity and impact on quality of life.
  • The findings suggest that while no official treatment guidelines for psoriasis in DS patients exist, anti-TNFα drugs like adalimumab and newer anti-interleukin medications show promise with good tolerability and effectiveness.
View Article and Find Full Text PDF

Hepatic cysts have become increasingly frequent findings thanks to the improvement in diagnostic investigations. Distinction has to be made between congenital hepatic cysts (like liver cyst, PLCD) and acquired forms (such as a parasitic cyst and a cyst occurring as part of a neoplastic process) (1). When a simple hepatic cyst becomes symptomatic, when its size is > 4 cm or when there is some radiological suspicion of malignancy (thick wall, peripheral enhancement on CT/MRI) surgical management is indicated and relies on a variety of techniques (2).

View Article and Find Full Text PDF

Background: Recently it has been reported that apremilast might promote melanogenesis and it would therefore not be safe to use this drug in patients with psoriasis who have a history of melanoma.

Methods: From January 2017 to December 2020, we retrospectively identified, within a cohort of 635 patients in follow-up care for melanoma, 16 cases of patients with psoriasis treated with apremilast and history of melanoma. Patients were monitored at our unit for a mean duration of 36 months of follow up.

View Article and Find Full Text PDF

Atopic dermatitis is a Th2 disease, due to relapse of IL-4 and IL-13 by Th2 cells. Despite the approval by FDA of dupilumab, the first monoclonal antibody for the severe forms, traditional drugs remain a milestone for the treatment of this dermatosis. Dermatologists need a good knowledge of all therapies for an integrated and personalized management of patients.

View Article and Find Full Text PDF

Background: Mental disorders in comorbidity with chronic skin diseases may worsen disease outcome and patients' quality of life. We hypothesized the comorbidity of depression, anxiety syndromes, or symptoms as attributable to biological mechanisms that the combined diseases share.

Methods: We conducted a systematic review based on the Preferred Reporting Items for Systematic Review and Meta-Analysis statement searching into PubMed, PsycInfo, and Scopus databases.

View Article and Find Full Text PDF